Company profile
America Great Health CIK 1098009
Ticker
AAGH (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Alhambra, CA 91803
Fiscal year end
2025 (FY)
Key Financials
Revenue
$391.7K
Net income
-$719.1K
Total assets
$301.8K
Total liabilities
$6.05M
Stockholders' equity
-$5.66M
Cash & equivalents
$44.1K
Operating income
-$382.9K
Operating cash flow
-$332.9K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-04-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-97.8%
Net margin
-183.6%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
2,003.1%
Equity / assets
-1,875.7%
CapEx / revenue
—
Operating cash flow / net income
0.46×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$391.7K
-$719.1K
$301.8K
$6.05M
-$5.66M
2024
$294.7K
-$1.22M
$323.5K
$5.45M
-$5.04M
2023
$204.3K
-$761.4K
$299.1K
$4.67M
-$4.30M
2022
$104.6K
-$4.92M
$336.1K
$4.20M
-$3.80M
2021
$195.7K
-$269.1K
$623.0K
$1.09M
-$467.8K
Company Details
SIC code
2834
State of incorporation
CA
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-24
Financials filed via
Form 10-K
filed 2026-04-10
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Alhambra, CA 91803
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:15 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.